Coronary Stent Market Research Report: By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bio Absorbable Stents), by Mode of Delivery (Balloon-Expandable Stents and Self-Expanding Stents), by End-User (Hospitals & Clinics) – Global Forecast Till 2023
Coronary Stent Market Overview
Coronary stents are a small tube-like device that is placed into the coronary arteries of a patient in order to keep the arteries open in the coronary heart disease treatment and prevent the same from any kind of blockage. It is used for broadening the narrowed arteries and helps curb-down chest pain and the chances of heart attack. According to the recently published report by the team of Market Research Future (MRFR), the global coronary stent market is projected to grow at a rate of 7.8% during the review period.
Get a FREE Sample Copy of Report with Complete TOC @ https://www.marketresearchfuture.com/sample_request/5915
The market is identified to be driven by a number of factors, including the wide-spread prevalence of heart-related diseases and a proliferating demand for diagnosis and treatment methods. Additionally, the growing availability of diagnostic services for coronary heart diseases is also pushing the growth of the market. A growing percentage of positive outcomes with stenting and the emergence of a number of advancing technologies in the coronary artery field is adding to the market growth of the device. It is also worth noting that alternative treatment methods for curing coronary artery diseases and a number of product recall cases are likely to hinder the market growth of coronary stents.
Coronary Stent Market Segmentation
Global coronary stent market size segmentation is classified on the basis of mode of delivery, type, material, and end-user.
By type, the market segments into drug-eluting stents, bioabsorbable stents, and bare-metal stents.
By material, the market comprises cobalt chromium, metallic stents, stainless steels, platinum chromium, nickel titanium, and others.
By end-user, the market includes hospitals and clinics, ambulatory surgical centers, cardiac centers, and others.
By mode of delivery, the market divides into self-expanding and balloon-expandable stents.
Coronary Stent Market Regional Analysis
The regional analysis of the global coronary stent market segments into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.
North America is the dominant region of the lot and is primarily driven by the surging patient population suffering from coronary heart diseases, an increasing pool of geriatric population, and growing investments in the healthcare sector. Latin America, on the other hand, is slated to be one of the fastest growing regional market owing to the rising demand for coronary heart disease treatment options and the availability of technologically advanced devices for diagnosis purposes.
With Germany and the UK being the major contributors, the European coronary stent market is expected to flourish in the forthcoming years. An increasing emphasis on the diagnosis and treatment of heart and other related diseases has majorly driven the market in this region. The increasing healthcare expenditure is another key contributor to the market’s growth.
Asia-Pacific stands out as the fastest growing market amongst all the mentioned regions. This projection can be primarily attributed to the increasing prevalence of cardiovascular diseases and a rising focus on performing early diagnosis and treatment of heart diseases. The Middle East & African region is forecasted to exhibit a slow and steady rise in the growth ladder. The regional market is starting to show positive signs with an increasing number of healthcare facilities offering treatments for chronic diseases and an increasing growth of the medical device sector, especially for diagnostic devices. In Africa, increasing awareness concerning coronary heart diseases is pushing the market growth herein.
Coronary Stent Market Competitive Landscape
The market includes some highly noteworthy players including B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Vascular Concepts (India), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Translumina GmbH (Germany), Biosensors International Group, Ltd. (Singapore), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (U.S.), Boston Scientific Corporation (U.S.), STENTYS SA (France), Medtronic plc (Ireland), Abbott Laboratories (U.S.), Reva Medical Inc. (U.S.), and others.
Coronary Stent Industry Overview
Feb 8th, 2019, CeloNova BioSciences, Inc. (CeloNova), an innovative global medical device leader, announced the signing of a three-year group purchasing agreement with HealthTrust for their new game-changing Coronary Stent named COBRA PzF(TM) NanoCoated Coronary Stent (NCS) System.
Feb 22nd, 2019, Biotronic announced the approval of Osiro, an ultrathin-strut coronary stent, from the US Food and Drug Administration for the treatment of coronary artery disease. It was approved in Europe eight years back and has been implanted upon millions of patients globally.
Get More Information on Coronary Stent Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/coronary-stent-market-5915
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The report Respiratory Pathogen Testing Market by Key players highlights the essential market dynamics of Respiratory Pathogen Testing Market sector.
The proficiency of this fragment has been analyzed profoundly alongside the imperative challenges and approaching improvement openings and forthcoming.
The report considerations in judgment creation capacities and supports to make incredible counter procedures to achieve competitive advantage.
Current market circumstance of the section and gauges of the market situation have additionally been limited in this market report.Scope of this Report:The business report centered on our unique research methodology delivers comprehensive analytical appraisal of this Global Respiratory Pathogen Testing Market spread across several sections.
The report moreover is made out of current estimations and format of this market with this industry joined with surmise possibilities.
Also, the key Market players of Respiratory Pathogen Testing are examined in many aspects like company summary, product portfolio, and sales details throughout the year.
The ‘Global Immunohematology Market’ Report recently published by Reports and Data provides a comprehensive examination of the critical development patterns found in the business.
The report is an exclusive document containing valuable data and information about the growth of the industry.
The report includes beneficial insights about the market dynamics, profit margins, market share, gross revenue, and other fundamental segments of the market for the forecast period of 2020-2026.
The report includes the impact of the COVID-19 pandemic on the Immunohematology industry.
The report offers an in-depth analysis of the market size, market share, and market growth and its estimation through the forecast years on the basis of the COVID-19 crisis.
The report explores the present and future impact of the pandemic and provides an insight into the market scenario in the post-pandemic world.Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2251The key companies operating in the Immunohematology market are as follows:Siemens Healthcare GmbH, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Grifols, Immucor, Abbott laboratories, Beckman Coulter, ThermoFisher, Becton Dickinson and Merck KGaAKey Aspects of the Immunohematology Market Report:Extensive Analysis of the Regional Landscape: The report extensively studies the major geographical regions for the analysis of market size, share, growth, and trends.
This report studies the global market size of Clinical Immunoassay Analyzers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Clinical Immunoassay Analyzers in these regions.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.
The key manufacturers in the Clinical Immunoassay Analyzers include :
Market Size Split by Type
Market Size Split by Application
Gain Full Access of Global Clinical Immunoassay Analyzers Market with complete TOC at https://www.orbisresearch.com/reports/index/global-clinical-immunoassay-analyzers-market-insights-forecast-to-2025 .
Market growth is largely driven by factors such as the increasing prevalence of influenza, growth in research funding for influenza diagnostics, and the rising demand for faster diagnosis are the major factors that are expected to drive the growth of this market in the coming years.
However, variability in sensitivity and specificity among influenza diagnostic tests, the presence of a complex regulatory framework for the approval of new diagnostic tests, and rising healthcare costs are expected to restrain the growth of this market to a certain extent in the coming years.
The global influenza diagnostics market is expected to grow from USD 695 million in 2020 to USD 1,012 million by 2025, at a CAGR of 7.8% during the forecast period.
Influenza Diagnostics Market by Test type (Molecular (RT-PCR,LAMP, NASBA), Traditional (Viral Culture, Direct Fluorescent Antibody, Rapid Influenza Detection Tests, Serological Assays)), End user (Hospital, Clinical Laboratories) - Global Forecast to 2025 Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222985562 Global Influenza Diagnostics Market is Segmented into: Test TypeEnd UserTest Type Based on the test type, the influenza diagnostics market is segmented into traditional diagnostic tests and molecular diagnostic tests.
The large share of this segment can be attributed to increased adoption of cost-effective and faster RIDT as a first line of diagnosis and screening process have been raised among the end-users.
End User Based on end-user, the global influenza diagnostic market is divided into hospitals, clinical laboratories, and other end users.
The global bio-microelectromechanical systems (MEMS) market has been projected in a report by Research Report Insights (RRI) to bear a fairly consolidated vendor landscape.
With a view to improve their product portfolio, these players have been taking to continuous research and development and the development of novel products with consistent efforts.
In order to stay dominant in the market and gain a larger share, companies could consider strategizing key mergers and acquisitions.The global bio-MEMS market has been foreseen in the RRI report to grow at a CAGR of 20.9% during the forecast 2024.
By region, North America could take a leading position in the market while garnering a dominant share of 37.4% by the closure of 2024.Request For Report Sample: https://www.researchreportinsights.com/report/sample/110114889/Bio-MEMS-MarketIncreasing Applications of Tissue Engineering Create Ground for More Demand Tissue engineering widening its applications in unconventional surgical procedures has been envisaged to create a phenomenal backdrop for the world bio-MEMS market to ride its progress on.
Terminally ill patients could be treated with the use of bio-MEMS sensors including topical sensors.
These have been predicted to be counted among the two most crucial factors driving growth in the market.Developed regions such as North America have been forecast to offer scores of positive business prospects in the coming years due to a strong provision of government grants reserved for the development of healthcare infrastructure.
Biochips Market OverviewAs per the latest report furnished by Market Research Future (MRFR), the global biochips market held the value of USD 7,300 million in 2017, with the growth rate of the market predicted at 16.6% over the forecast period (2018-2023).Biochips Market Growth Drivers and ChallengesMicrofluidics and Microarray technology have revolutionized the field of scientific research by reducing costs as well as time required for conventional laboratory-based approach of research.
Microfluidics provide various benefits like reduced assay costs owing to need for less amount of sample in nano-liter or pico liter volume, increased sensitivity, accuracy, and throughput as compared to traditional laboratory procedures and also reduced labor cost.
The products that are based on DNA microarrays, lab-on-a-chip, protein chips, as well as organ-on-a-chip technologies have managed to alleviate the existing problems associated with time and costs in their respective fields.
Also, the research and development activities are underway at present, regarding the microarray and microfluidic technologies for numerous applications.
The sum of all these factors, including various research and development activities along with the benefits offered by this technology, will prove to be highly beneficial for the biochips market growth in the near future.Biochips Market SegmentationThe global biochips market is segmented based on type, technology, and end user.Type-based segments in the global market include DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays.
On the basis of technology, the market is segmented into microarrays and microfluidics.The end users in the biochips market are biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.Browse Full Report with TOC at: https://www.marketresearchfuture.com/reports/biochips-market-7063Biochips Market Regional AnalysisRegionally, the global biochips market is split into the key regions of Europe, Asia Pacific, the Americas, along with the Middle East & Africa.The biochips market, in the Americas, is flourishing in the regions of North America and South America, wherein the North America market is further split into the United States (US) and Canada.
